Prescription Dermatology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Prescription Dermatology Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

Nov 2018 Transparency Market Research Pharmaceutical183 Pages Price :
$ 5795

Prescription Dermatology Therapeutics Market - Overview

This report by Transparency Market Research analyzes the global prescription dermatology therapeutics market for the period between 2018 and 2026. An in-depth and unbiased market assessment has been made which offers readers an in-depth and accurate analysis. Market projections have been offered in terms of value (US$ Mn). Stakeholders of this report include companies and intermediaries engaged in research & development, manufacture, and marketing of products prescribed in the treatment of various skin conditions.

The global prescription dermatology therapeutics market has been studied for the forecast period from 2018 to 2026. For research, 2017 has been considered as the base year and 2016 as the historical year. The global prescription dermatology therapeutics market report comprises an elaborate executive summary that provides overall information about various segments of the market. The report provides a detailed competitive landscape, by major players operating in this market along with their shares (value %) of the global prescription dermatology therapeutics market for 2017. The report also provides detailed company profiles of emerging market players operating in the global prescription dermatology therapeutics market.

The market overview section comprises impact factors such as key market dynamics including drivers, restraints, and opportunities, affecting the global prescription dermatology therapeutics market. These factors are likely to aid stakeholders establish a strong foothold in the global prescription dermatology therapeutics market. Furthermore, the market overview section comprises key industry events, pipeline analysis, key mergers & acquisitions across the dermatology industry, epidemiology analysis of the skin diseases, product portfolio overview of leading players, and market attractiveness analysis in the global prescription dermatology therapeutics market. The market attractiveness analysis provides a graphical view comparing the expansion and market dynamics in various segments and countries to identify the most attractive market.

Scope

The global prescription dermatology therapeutics market has been segmented based product type, distribution channel, and region. In terms of product type, the global market has been classified into acne & rosacea drugs, psoriasis drugs, dermatitis & seborrhea drugs, fungal infection drugs, skin cancer, and others. In terms of distribution channel, the global prescription dermatology therapeutics market has been categorized into hospital pharmacies, retail pharmacies, and mail order pharmacies.

In terms of region, the global prescription dermatology therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, quantitative analysis for major countries comprising the U.S., Canada, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, and Australia & New Zealand has also been provided in the report. A detailed qualitative analysis of factors responsible for driving and restraining the global market in various regions has been provided in this section.

The report provides a detailed outline/blueprint of the global prescription dermatology therapeutics market which is expected to assist new companies establish their presence and companies to expand their share in the market. The report concludes with the company profiles section, which includes company overview, financial overview, SWOT analysis, product portfolio, business strategies, and recent developments of key players.

Competitive landscape

Major players operating in the global prescription dermatology therapeutics market include AbbVie, Inc., Janssen Biotech, Inc., Novartis AG, Amgen, Inc., Celgene Corporation, Pfizer, Inc., LEO Pharma A/S, Eli Lilly and Company, Bausch Health Companies, Inc., Sun Pharmaceuticals Ltd., Aclaris Therapeutics, Inc., and Aurobindo Pharma Ltd.

The global prescription dermatology therapeutics market has been segmented into:

Global Prescription Dermatology Therapeutics Market, by Product Type

  • Acne & Rosacea Drugs
  • Psoriasis Drugs
  • Dermatitis & Seborrhea Drugs
  • Fungal Infection Drugs
  • Skin Cancer Drugs
  • Others

Global Prescription Dermatology Therapeutics Market, by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Mail Order Pharmacies

Global Prescription Dermatology Therapeutics Market, by Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • U.K.
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Prescription Dermatology Therapeutics Market

4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Prescription Dermatology Therapeutics Market Analysis and Forecast, 2016–2026 
4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook
5.1.Pipeline Analysis
5.2.Key Mergers & Acquisitions 
5.3.Disease Prevalence & Incidence Rate globally with key countries

6. Global Prescription Dermatology Therapeutics Market Analysis and Forecast, by Product Type 
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2016–2026
6.3.1. Acne & Rosacea Drugs
6.3.2. Psoriasis Drugs
6.3.3. Dermatitis & Seborrhea Drugs
6.3.4. Fungal Infection Drugs
6.3.5. Skin Cancer Drugs
6.3.6. Others
6.4. Market Attractiveness, by Product Type 

7. Global Prescription Dermatology Therapeutics Market Analysis and Forecast, by Distribution Channel 
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Distribution Channel, 2016–2026
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Mail Order Pharmacies
7.4. Market Attractiveness, by Distribution Channel 

8. Global Prescription Dermatology Therapeutics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America 
8.2.2. Europe 
8.2.3. Asia Pacific 
8.2.4. Latin America 
8.2.5. Middle East & Africa 
8.3. Market Attractiveness, by Country/Region

9. North America Prescription Dermatology Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2016–2026
9.2.1. Acne & Rosacea Drugs
9.2.2. Psoriasis Drugs
9.2.3. Dermatitis & Seborrhea Drugs
9.2.4. Fungal Infection Drugs
9.2.5. Skin Cancer Drugs
9.2.6. Others
9.3. Market Value Forecast, by Distribution Channel, 2016–2026
9.3.1. Hospital Pharmacies
9.3.2. Retail Pharmacies
9.3.3. Mail Order Pharmacies
9.4. Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis 
9.5.1. By Product Type 
9.5.2. By Distribution Channel 
9.5.3. By Country

10. Europe Prescription Dermatology Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2016–2026
10.2.1. Acne & Rosacea Drugs
10.2.2. Psoriasis Drugs
10.2.3. Dermatitis & Seborrhea Drugs
10.2.4. Fungal Infection Drugs
10.2.5. Skin Cancer Drugs
10.2.6. Others
10.3. Market Value Forecast, by Distribution Channel, 2016–2026
10.3.1. Hospital Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Mail Order Pharmacies
10.4. Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis 
10.5.1. By Product Type 
10.5.2. By Distribution Channel 
10.5.3. By Country/Sub-region

11. Asia Pacific Prescription Dermatology Therapeutics Market Analysis and Forecast
11.1.Introduction
11.1.1. Key Findings
11.2.Market Value Forecast, by Product Type, 2016–2026
11.2.1. Acne & Rosacea Drugs
11.2.2. Psoriasis Drugs
11.2.3. Dermatitis & Seborrhea Drugs
11.2.4. Fungal Infection Drugs
11.2.5. Skin Cancer Drugs
11.2.6. Others
11.3.Market Value Forecast, by Distribution Channel, 2016–2026
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Mail Order Pharmacies
11.4.Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5.Market Attractiveness Analysis 
11.5.1. By Product Type 
11.5.2. By Distribution Channel 
11.5.3. By Country/Sub-region

12. Latin America Prescription Dermatology Therapeutics Market Analysis and Forecast
12.1.Introduction
12.1.1. Key Findings
12.2.Market Value Forecast, by Product Type, 2016–2026
12.2.1. Acne & Rosacea Drugs
12.2.2. Psoriasis Drugs
12.2.3. Dermatitis & Seborrhea Drugs
12.2.4. Fungal Infection Drugs
12.2.5. Skin Cancer Drugs
12.2.6. Others
12.3.Market Value Forecast, by Distribution Channel, 2016–2026
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Mail Order Pharmacies
12.4.Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5.Market Attractiveness Analysis 
12.5.1. By Product Type 
12.5.2. By Distribution Channel 
12.5.3. By Country/Sub-region

13. Middle East & Africa Prescription Dermatology Therapeutics Market Analysis and Forecast
13.1.Introduction
13.1.1. Key Findings
13.2.Market Value Forecast, by Product Type, 2016–2026
13.2.1. Acne & Rosacea Drugs
13.2.2. Psoriasis Drugs
13.2.3. Dermatitis & Seborrhea Drugs
13.2.4. Fungal Infection Drugs
13.2.5. Skin Cancer Drugs
13.2.6. Others
13.3 Market Value Forecast, by Distribution Channel, 2016–2026
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Mail Order Pharmacies
13.4.Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5.Market Attractiveness Analysis 
13.5.1. By Product Type 
13.5.2. By Distribution Channel 
13.5.3. By Country/Sub-region

14. Competition Landscape
14.1.Market Player - Competition Matrix (By Tier and Size of companies)
14.2.Market Share Analysis By Company (2017)
14.3. Company Profiles
14.3.1. AbbVie, Inc. 
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Financial Overview
14.3.1.5. Strategic Overview
14.3.2. Janssen Biotech, Inc.
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Financial Overview
14.3.2.5. Strategic Overview 
14.3.3. Novartis AG 
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Financial Overview
14.3.3.5. Strategic Overview
14.3.4. Amgen, Inc. 
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Financial Overview
14.3.4.5. Strategic Overview
14.3.5. Celgene Corporation
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Financial Overview
14.3.5.5. Strategic Overview
14.3.6. Pfizer, Inc. 
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Financial Overview
14.3.6.5. Strategic Overview
14.3.7. LEO Pharma A/S 
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Financial Overview
14.3.7.5. Strategic Overview
14.3.8. Eli Lilly and Company
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Financial Overview
14.3.8.5. Strategic Overview
14.3.9. Bausch Health Companies, Inc.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Financial Overview
14.3.9.5. Strategic Overview 
14.3.10. Sun Pharmaceuticals Ltd. 
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Financial Overview
14.3.10.5. Strategic Overview
14.3.11. Aclaris Therapeutics, Inc.
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Financial Overview
14.3.11.5. Strategic Overview 
14.3.12. Aurobindo Pharma Ltd 
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Product Portfolio
14.3.12.3. SWOT Analysis
14.3.12.4. Financial Overview
14.3.12.5. Strategic Overview

List of Table

Table 01: Global Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 02: Global Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 03: Global Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 04: North America Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 05: North America Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 06: North America Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 07: Europe Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 08: Europe Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product, 2016–2026
Table 09: Europe Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 10: Asia Pacific Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 11: Asia Pacific Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 12: Asia Pacific Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 13: Latin America Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 14: Latin America Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 15: Latin America Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 16: Middle East & Africa Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Middle East & Africa Prescription Dermatology Therapeutics Value (US$ Mn) Forecast, by Product, 2016–2026
Table 18: Middle East & Africa Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, by Distribution Channel, 2016–2026

List of Chart

Figure 01: Global Prescription Dermatology Therapeutics Market Snapshot
Figure 02: Global Fluid Management Market Size (US$ Mn) and Distribution, by Region, 2017 and 2025
Figure 03: Global Prescription Dermatology Therapeutics Market Value (US$ Mn) Forecast, 2016-2026
Figure 05: Global Prescription Dermatology Therapeutics Market Value Share (%), by Distribution Channel (2017)
Figure 06: Global Prescription Dermatology Therapeutics Market Value Share (%), by Region (2017)
Figure 04: Global Prescription Dermatology Therapeutics Market Value Share (%), by Product Type (2017)
Figure 07: Global Prescription Dermatology Therapeutics Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 08: Global Prescription Dermatology Therapeutics Market Attractiveness, by Product Type, 2018–2026
Figure 09: Global Prescription Dermatology Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Acne & Rosacea Drugs, 2016–2026
Figure 10: Global Prescription Dermatology Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Psoriasis Drugs, 2016–2026
Figure 11: Global Prescription Dermatology Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Dermatitis & Seborrhea Drugs, 2016–2026
Figure 12: Global Prescription Dermatology Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Fungal Infection Drugs, 2016–2026
Figure 13: Global Prescription Dermatology Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Skin Cancer Drugs, 2016–2026
Figure 14: Global Prescription Dermatology Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2016–2026
Figure 15: Global Prescription Dermatology Therapeutics Market Value Share (%), by Distribution Channel, 2017 and 2026
Figure 17: Global Prescription Dermatology Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Retail Pharmacies, 2016–2026
Figure 18: Global Prescription Dermatology Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Mail Order Pharmacies, 2016–2026
Figure 16: Global Prescription Dermatology Therapeutics Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacies, 2016–2026
Figure 19: Global Prescription Dermatology Therapeutics Market Attractiveness, by Distribution Channel, 2018–2026
Figure 20: Global Prescription Dermatology Therapeutics Market Value Share Analysis, by Region 2017 and 2026
Figure 21: Global Prescription Dermatology Therapeutics Market Attractiveness, by Region, 2018–2026
Figure 22: North America Prescription Dermatology Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 23: North America Prescription Dermatology Therapeutics Market Value Share (%), by Country, 2017 and 2026
Figure 24: North America Prescription Dermatology Therapeutics Market Attractiveness, by Country, 2018–2026
Figure 25: North America Prescription Dermatology Therapeutics Market Value Share (%), by Product Type, 2017 and 2026
Figure 26: North America Prescription Dermatology Therapeutics Market Attractiveness, by Product Type, 2018–2026
Figure 27: North America Prescription Dermatology Therapeutics Market Value Share (%), by Distribution Channel, 2017 and 2026
Figure 28: North America Prescription Dermatology Therapeutics Market Attractiveness, by Distribution Channel, 2018–2026
Figure 29: Europe Prescription Dermatology Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 30: Europe Prescription Dermatology Therapeutics Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 31: Europe Prescription Dermatology Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 32: Europe Prescription Dermatology Therapeutics Market Value Share (%), by Product, 2017 and 2026
Figure 33: Europe Prescription Dermatology Therapeutics Market Attractiveness, by Product, 2018–2026
Figure 34: Europe Prescription Dermatology Therapeutics Market Value Share (%), by Distribution Channel, 2017 and 2026
Figure 35: Europe Prescription Dermatology Therapeutics Market Attractiveness, by Distribution Channel, 2018–2026
Figure 36: Asia Pacific Prescription Dermatology Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 37: Asia Pacific Prescription Dermatology Therapeutics Market Value Share (%), by Country/Sub-region, 2017 and 2026
Figure 38: Asia Pacific Prescription Dermatology Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 39: Asia Pacific Prescription Dermatology Therapeutics Market Value Share (%), by Product Type, 2017 and 2026
Figure 40: Asia Pacific Prescription Dermatology Therapeutics Market Attractiveness, by Product Type, 2018–2026
Figure 41: Asia Pacific Prescription Dermatology Therapeutics Market Value Share (%), by Distribution Channel, 2017 and 2026
Figure 42: Asia Pacific Prescription Dermatology Therapeutics Market Attractiveness, by Distribution Channel, 2018–2026
Figure 43: Latin America Prescription Dermatology Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 44: Latin America Prescription Dermatology Therapeutics Market Value Share (%), by Country/Sub-region 2017 and 2026
Figure 45: Latin America Prescription Dermatology Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 46: Latin America Prescription Dermatology Therapeutics Market Value Share (%), by Product Type, 2017 and 2026
Figure 47: Latin America Prescription Dermatology Therapeutics Market Attractiveness, by Product Type, 2018–2026 
Figure 48: Latin America Prescription Dermatology Therapeutics Market Value Share (%), by Distribution Channel, 2017 and 2026
Figure 49: Latin America Prescription Dermatology Therapeutics Market Attractiveness, by Distribution Channel, 2018–2026
Figure 50: Middle East & Africa Prescription Dermatology Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 51: Middle East & Africa Prescription Dermatology Therapeutics Market Value Share (%), by Country/Sub-region 2017 and 2026
Figure 52: Middle East & Africa Prescription Dermatology Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 53: Middle East & Africa Prescription Dermatology Therapeutics Market Value Share (%), by Product, 2017 and 2026
Figure 54: Middle East & Africa Prescription Dermatology Therapeutics Market Attractiveness, by Product, 2018–2026
Figure 55: Middle East & Africa Prescription Dermatology Therapeutics Market Value Share (%), by Distribution Channel, 2017 and 2026
Figure 56: Middle East & Africa Prescription Dermatology Therapeutics Market Attractiveness, by Distribution Channel, 2018–2026
Figure 57: Global Prescription Dermatology Therapeutics Market Share Analysis, by Company (2017)
Figure 58: AbbVie, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 59: AbbVie, Inc. R&D Intensity and Sales & Marketing Intensity - Company Level, 2015–2016
Figure 60: AbbVie, Inc. Breakdown of Net Sales (%), by Region
Figure 61: Janssen Biotech, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 62: Breakdown of Net Sales (%), by Business Segment, (2017)
Figure 63: Janssen Biotech, Inc. Breakdown of Net Sales (%), by Geography (2017)
Figure 64: Janssen Biotech, Inc. R&D Intensity and Sales & Marketing Intensity - Company Level, 2016–2017
Figure 65: Janssen Biotech, Inc. Breakdown of Net Sales, by Geography (2017)
Figure 66: Janssen Biotech, Inc. Breakdown of Net Sales, by Business Segment (2017)
Figure 67: Janssen Biotech, Inc. R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017
Figure 68: Janssen Biotech, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
Figure 69: Amgen, Inc. R&D Intensity and Sales & Marketing Intensity - Company Level, 2016–2017
Figure 70: Amgen, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 71: Amgen, Inc. Breakdown of Net Sales, by Region, 2017
Figure 72: Celgene Corporation Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 73: Celgene Corporation Breakdown of Net Sales (%), by Key Product (2017)
Figure 74: Celgene Corporation R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017
Figure 75: Celgene Corporation Breakdown of Net Sales, by Geography (2017)
Figure 76; Pfizer, Inc. Breakdown of Net Sales, by Region, 2017
Figure 78: Pfizer, Inc. R&D Intensity and Sales & Marketing Intensity - Company Level, 2016–2017
Figure 79: LEO Pharma A/S Breakdown of Net Sales, by Geography (2017)
Figure 80: LEO Pharma A/S Breakdown of Net Sales, by Therapeutic Area (2017)
Figure 81: LEO Pharma A/S Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 82; Eli Lilly and Company Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 83; Eli Lilly and Company Breakdown of Net Sales (%), by Region, 2017
Figure 84 Eli Lilly and Company Research & Development Cost (US$ Mn), 2016 and 2017
Figure 85: Eli Lilly and Company Breakdown of Net Sales (%), by Business Segment, 2017
Figure 86: Bausch Health Companies, Inc. R&D Expenses (US$ Mn), 2015-2017
Figure 87: Bausch Health Companies, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2017
Figure 88: Bausch Health Companies, Inc. Breakdown of Net Sales (%), by Region, 2016
Figure 89: Allergan plc. R&D Intensity and Sales & Marketing Intensity – Company Level, 2016–2017
Figure 90: Allergan plc. Breakdown of Net Sales, by Business Segment (2017)
Figure 91: Allergan plc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2013–2017
Figure 92: Sun Pharmaceuticals Ltd. Breakdown of Net Sales, by Geography (2017)
Figure 93: Sun Pharmaceuticals Ltd. Breakdown of Net Sales, by Business Segment (2017)
Figure 94: Sun Pharmaceuticals Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 95: Aclaris Therapeutics, Inc. R&D Expenses (US$ Mn), 2013–2016
Figure 96: Aurobindo Pharma Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
Figure 97: Aurobindo Pharma Ltd. Breakdown of Net Sales, by Business Segment (2017)

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 5795
$ 8795

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top